月度归档： 2026 年 9 月

The results of a preclinical study by researchers at the University of East Anglia suggest that an experimental anticancer drug could stop osteoporosis and help women prevent weight gain after the menopause. Their study in mice found that the small molecule drug CADD522 not only protected against osteoporosis but could also reduce body fat and reverse some of the metabolic changes linked to menopause. Currently in development for cancer therapy, CADD522 is a small molecule inhibitor of the transcription factor RUNX2, which is helps to drive the growth and spread of several cancers.

RNAV8 Bio (pronounced Renovate Bio) has been selected to receive funding from the Advanced Research Projects Agency for Health (ARPA-H) for PROPEL (Programmable RNA for Optimal Precision in Therapeutic Efficacy and Localization).

France-based Clean Cells launched its next-generation sequencing (NGS)-based safety testing for viral matrices, such as viral vectors and recombinant preparations. The company also announced that it had acquired French bioinformatics CRO Xegen, which specializes in NGS data analysis.

Biotech company Moonwalk Biosciences announced that it has raised $70 million from an oversubscribed series B financing round. The company plans to use the funds to continue developing its adipose-targeted RNAi therapies for obesity and cardiometabolic conditions. 

Clear, sparkling drinks are leading the next wave of the protein craze.Consumers want options that don’t feel as dense or heavy as protein shakes. Vy Cutting was one of them.

The role of artificial intelligence (AI) in ingredient discovery is becoming increasingly prominent, with the technology significantly cutting the timelines and costs associated with such research.